Abstract | OBJECTIVE: To understand the anti-virus adaptive immune response occurring during SARS-Cov-2 infection is necessary to have methods to investigate cellular and humoral components. The goal of this study has been to investigate the utility of a specific spike-DTH test using a coronavirus recombinant protein in COVID-19 patients. METHODS: DTH studies were performed by intradermal injection of a commercial recombinant spike protein from SARS-CoV-2 along with conventional serology studies. RESULTS: Fifty-one COVID-19 patients were studied showing 84,3% of concordance with spike-DTH and anti-RBD- IgG. Spike-DTH was superior to identify seven more COVID-19 individuals. A high specificity was found with no positive spike DTH reactions in the non-sick individuals. The skin test also showed more stable results over time while specific anti-RBD- IgG decreased gradually. Clinical severity groups also showed a progressive gradient of larger positive spike-DTH. CONCLUSION: Specific spike DTH test seems to be an easy method to study cell immune response.
|
Authors | Yvelise Barrios, Andres Franco, Inmaculada Sanchez-Machin, Paloma Poza-Guedes, Ruperto Gonzalez-Perez, Victor Matheu |
Journal | Clinical immunology (Orlando, Fla.)
(Clin Immunol)
Vol. 226
Pg. 108730
(05 2021)
ISSN: 1521-7035 [Electronic] United States |
PMID | 33865990
(Publication Type: Journal Article)
|
Copyright | Copyright © 2021 Elsevier Inc. All rights reserved. |
Chemical References |
- Antibodies, Viral
- Immunoglobulin G
- Recombinant Proteins
- Spike Glycoprotein, Coronavirus
- spike protein, SARS-CoV-2
|
Topics |
- Antibodies, Viral
(blood)
- COVID-19
(immunology)
- COVID-19 Serological Testing
(methods)
- Female
- Humans
- Hypersensitivity, Delayed
(immunology)
- Immunity, Cellular
- Immunoglobulin G
(blood)
- Injections, Intradermal
- Male
- Middle Aged
- Protein Domains
- Recombinant Proteins
- SARS-CoV-2
(genetics)
- Spike Glycoprotein, Coronavirus
(immunology)
|